Kathleen Quirk

Statistics

Publications

Citations

1.8K

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Wokingham Hospital

Texas A&M University

Kathleen Quirk is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in neuropharmacology, pharmacology, and receptor pharmacology.

Publications per year

1990–2007

Publications

Pharmacological characterisation of the agonist radioligand binding site of 5-HT2A, 5-HT2B and 5-HT2C receptors

Anil Kumar Misra, Kathleen Quirk, Karen Benwell et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 241 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

GABAA receptor subtypes immunopurified from rat brain with α subunit-specific antibodies have unique pharmacological properties

Ruth M. McKernan, Kathleen Quirk, Richard J. Prince et al. · Neuron · 1991 · 198 citations

Life Sciences, Neuroscience, Pharmacology +12

A novel allosteric modulatory site on the GABAA receptor β subunit

Keith A. Wafford, C Bain, Kathleen Quirk et al. · Neuron · 1994 · 184 citations

Medicine, Neuroscience, Pharmacology +14

[ 3 H]L-655,708, a Novel Ligand Selective for the Benzodiazepine Site of GABA A Receptors which Contain the α5 Subunit

Kathleen Quirk, Peter Blurton, Stephen R. Fletcher et al. · Neuropharmacology · 1996 · 180 citations

Medicine, Neuroscience, Pharmacology +16

Model of subunit composition of gamma-aminobutyric acid A receptor subtypes expressed in rat cerebellum with respect to their alpha and gamma/delta subunits.

Kathleen Quirk, N.P. Gillard, C I Ragan et al. · Journal of Biological Chemistry · 1994 · 119 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

1–5 of 24